Prince Street Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-62,800
Closed -$10.8M 57
2018
Q3
$10.8M Buy
62,800
+12,500
+25% +$2.1M 2.29% 10
2018
Q2
$7.73M Sell
50,300
-255,200
-84% -$45.5M 1.59% 16
2018
Q1
$51.3M Sell
305,500
-45,300
-13% -$6.14M 9.68% 3
2017
Q4
$34.3M Buy
350,800
+5,000
+1% +$458K 6.43% 4
2017
Q3
$35.8M Buy
345,800
+98,900
+40% +$7.37M 5.95% 3
2017
Q2
$11.1M Hold
246,900
1.8% 18
2017
Q1
$9.04M Hold
246,900
2.08% 17
2016
Q4
$7.5M Buy
246,900
+111,500
+82% +$3.5M 2.36% 14
2016
Q3
$4.17M Hold
135,400
0.77% 28
2016
Q2
$4.04M Hold
135,400
1.07% 22
2016
Q1
$3.97M Buy
+135,400
New +$3.84M 0.81% 27

Other funds holding ONC

Prince Street Capital Management's ONC Position: Q4 2018 in Review

Prince Street Capital Management sold out of BeOne Medicines Ltd (ONC) in Q4 2018, closing a stake of 62,800 shares — an estimated $10.8M sold.

Prince Street Capital Management first reported a position in ONC in Q1 2016 and held it in 11 quarters. The position peaked at $51.3M in Q1 2018. 192 funds tracked by Wall St. Rank hold ONC as of Q4 2018.

  • Prince Street Capital Management reported no remaining BeOne Medicines Ltd position as of Q4 2018 after selling out during the quarter.
  • Prince Street Capital Management sold 62,800 BeOne Medicines Ltd shares in Q4 2018, an estimated $10.8M.
  • Prince Street Capital Management first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 11 quarters.
  • Prince Street Capital Management's BeOne Medicines Ltd position peaked at $51.3M in Q1 2018.
  • 192 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2018.

Based on Prince Street Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.